About Us

Who We Are

Qvella develops innovative solutions based on a proprietary technology - FAST™ - designed to enable faster microbiology results to improve the management and outcome of patients suspected of sepsis.

Global headquarter is located in Richmond Hill, Ontario, Canada; local offices are located in Carlsbad, California, and Mechelen, Belgium.

Leadership Team

Tino Alavie, Ph.D.

President & CEO

Dr. Tino Alavie is the President and CEO of Qvella. Tino has the primary responsibility of leading the company’s full range of Research and Development initiatives. Prior to founding Qvella, he was founder, CEO and executive chairman of NOVX Systems Inc..

Click to read more

Stephen Clark, M.S.

Vice President of Marketing

Mr. Steve Clark is Vice President of Marketing. Steve is an experienced marketing professional with multiple successes in commercializing new clinical diagnostic products in markets worldwide.

Click to read more

David A. Haake, M.D.

Chief Medical Officer

Dr. David Haake our Chief Medical Officer. David is an experienced clinician scientist in the fields of infectious diseases, bacterial pathogenesis, vaccine development, and in vitro diagnostics with a number of patents and patent applications and ~130 publications in the scientific literature....

Click to read more

Aye Aye Khine, Ph.D.

Principal Scientist

Dr. AyeAye Khine is a Principal Scientist at Qvella. Early in her graduate career, Aye Aye’s research focused on the mechanism of verotoxin produced from Escherichia coli in the pathogenesis of hemolytic uremic syndrome...

Click to read more

Stephen Leonard, Ph.D.

Intellectual Property and Strategy

Dr. Stephen Leonard is focused on Intellectual Property and Strategy at Qvella. Stephen began his career as a scientist working on optical design and product development, later transitioning to business development and intellectual property (IP) management...

Click to read more

Robert Maaskant, P. ENG., Ph.D.

Vice President of Product Development

Dr. Robert Maaskant is Vice President of Product Development. Robert has a long history of successful technology product development and has held senior positions in both private start-ups as well as publicly held companies...

Click to read more

Glenn Magnuson, B.Sc.

Vice President of Business Development

Mr. Glenn Magnuson is Vice President of North American Sales. Glenn will be focusing on Business Development activities as he transitions to building and managing the sales...

Click to read more

Susan Novak-Weekley, Ph.D., D(ABMM), S(M) ASCP

Vice President of Medical Affairs

Dr. Susan Novak-Weekley is the Vice President of Medical Affairs at Qvella. Susan completed a post-doctoral fellowship in Clinical and Public Health Microbiology at the University of California,...

Click to read more

Samad Talebpour, Ph.D.

Chief Scientist

Dr. Samad Talebpour is a Chief Scientist at Qvella. Samad began his career as a laser physicist working on the interaction of high power laser generated electric fields with biological matter at Laval University in Quebec City..

Click to read more

Herbert Torfs, Ph.D.

Vice President of Business Development EMEA

Dr. Herbert Torfs is a seasoned Marketing and Business Development professional with 18 plus years of experience in the Clinical Diagnostics and Medical Device Industry. As the Vice President of Business Development EMEA...

Click to read more

Join Us

Qvella's Field Activated Sample Treatment (FAST™) technology

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives.

Know More